Advisory Commission on Childhood Vaccines; Notice of Meeting, 58300 [E9-27158]

Download as PDF 58300 Federal Register / Vol. 74, No. 217 / Thursday, November 12, 2009 / Notices Dated: November 4, 2009. Alexandra Huttinger, Director, Division of Policy Review and Coordination. [FR Doc. E9–27158 Filed 11–10–09; 8:45 am] DEPARTMENT OF HEALTH AND HUMAN SERVICES Health Resources and Services Administration BILLING CODE 4165–15–P Advisory Commission on Childhood Vaccines; Notice of Meeting jlentini on DSKJ8SOYB1PROD with NOTICES In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), notice is hereby given of the following meeting: Name: Advisory Commission on Childhood Vaccines (ACCV). Date and Time: December 4, 2009, 1 p.m. to 5:30 p.m. EST. December 5, 2009, 9 a.m. to 12:30 p.m. EST. Place: Parklawn Building (and via audio conference call), Conference Rooms G & H, 5600 Fishers Lane, Rockville, MD 20857. The ACCV will meet on Thursday, December 4 from 1 p.m. to 5:30 p.m. (EST) and Friday, December 5 from 9 a.m. to 12:30 p.m. (EST). The public can join the meeting via audio conference call by dialing 1–888– 323–2713 on December 4 & 5 and providing the following information: Leader’s Name: Dr. Geoffrey Evans. Password: ACCV. Agenda: The agenda items for the December meeting will include, but are not limited to: updates from the Division of Vaccine Injury Compensation (DVIC), Department of Justice, National Vaccine Program Office, Immunization Safety Office (Centers for Disease Control and Prevention), National Institute of Allergy and Infectious Diseases (National Institutes of Health), and Center for Biologics, Evaluation and Research (Food and Drug Administration). Agenda items are subject to change as priorities dictate. Public Comments: Persons interested in providing an oral presentation should submit a written request, along with a copy of their presentation to: Annie Herzog, DVIC, Healthcare Systems Bureau (HSB), Health Resources and Services Administration (HRSA), Room 11C–26, 5600 Fishers Lane, Rockville, Maryland 20857 or e-mail: aherzog@hrsa.gov. Requests should contain the name, address, telephone number, and any business or professional affiliation of the person desiring to make an oral presentation. Groups having similar interests are requested to combine their comments and present them through a single representative. The allocation of time may be adjusted to accommodate the level of expressed interest. DVIC will notify each presenter by mail or telephone of their assigned presentation time. Persons who do not file an advance request for a presentation, but desire to make an oral statement, may announce it at the time of the comment period. These persons will be allocated time as it permits. For Further Information Contact: Anyone requiring information regarding the ACCV should contact Annie Herzog, DVIC, HSB, HRSA, Room 11C–26, 5600 Fishers Lane, Rockville, MD 20857; telephone (301) 443– 6593 or e-mail: aherzog@hrsa.gov. VerDate Nov<24>2008 16:12 Nov 10, 2009 Jkt 220001 DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Center For Scientific Review; Notice of Closed Meetings Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: Center for Scientific Review Special Emphasis Panel; Review of Member Conflict HIV/AIDS Related Small Business Grant Applications. Date: December 2, 2009. Time: 12 p.m. to 1:30 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892 (Telephone Conference Call) Contact Person: Jose H. Guerrier, PhD, Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 5218, MSC 7852, Bethesda, MD 20892, 301–435– 1137, guerriej@csr.nih.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel; Neurodegenerative Disorders. Date: December 2, 2009. Time: 12 p.m. to 1 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892 (Telephone Conference Call) Contact Person: Deborah L. Lewis, PhD, Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 4118, MSC 7850, Bethesda, MD 20892, 301–435– 1224, lewisdeb@csr.nih.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel; Neurodevelopment and Plasticity. Date: December 3, 2009. Time: 1 p.m. to 3 p.m. Agenda: To review and evaluate grant applications. PO 00000 Frm 00062 Fmt 4703 Sfmt 4703 Place: National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892 (Telephone Conference Call) Contact Person: Laurent Taupenot, PhD, Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 4811, MSC 7850, Bethesda, MD 20892, 301–435– 1203, taupenol@csr.nih.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel; RFA–OD– 09–007: ARRA AREA Grants Panel 06. Date: December 4, 2009. Time: 8 a.m. to 6 p.m. Agenda: To review and evaluate grant applications. Place: Doubletree Hotel Bethesda, 8120 Wisconsin Avenue, Bethesda, MD 20814. Contact Person: Reed A. Graves, PhD, Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 6166, MSC 7892, Bethesda, MD 20892, (301) 402– 6297, gravesr@csr.nih.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel, RFA–OD– 09–007: ARRA AREA Grants Panel 04. Date: December 11, 2009, Time: 8 a.m. to 5 p.m. Agenda: To review and evaluate grant applications. Place: Hyatt Regency Bethesda, One Bethesda Metro Center, 7400 Wisconsin Avenue, Bethesda, MD 20814. Contact Person: Bill Bunnag, PhD, Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 3156, MSC 7770, Bethesda, MD 20892, (301) 435– 1177, bunnagb@csr.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.306, Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333, 93.337, 93.393–93.396, 93.837–93.844, 93.846–93.878, 93.892, 93.893, National Institutes of Health, HHS). Dated: November 5, 2009. Jennifer Spaeth, Director, Office of Federal Advisory Committee Policy. [FR Doc. E9–27212 Filed 11–10–09; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Heart, Lung, and Blood Institute; Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial E:\FR\FM\12NON1.SGM 12NON1

Agencies

[Federal Register Volume 74, Number 217 (Thursday, November 12, 2009)]
[Notices]
[Page 58300]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E9-27158]



[[Page 58300]]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Health Resources and Services Administration


Advisory Commission on Childhood Vaccines; Notice of Meeting

    In accordance with section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), notice is hereby given of the following 
meeting:

    Name: Advisory Commission on Childhood Vaccines (ACCV).
    Date and Time: December 4, 2009, 1 p.m. to 5:30 p.m. EST. 
December 5, 2009, 9 a.m. to 12:30 p.m. EST.
    Place: Parklawn Building (and via audio conference call), 
Conference Rooms G & H, 5600 Fishers Lane, Rockville, MD 20857.
    The ACCV will meet on Thursday, December 4 from 1 p.m. to 5:30 
p.m. (EST) and Friday, December 5 from 9 a.m. to 12:30 p.m. (EST). 
The public can join the meeting via audio conference call by dialing 
1-888-323-2713 on December 4 & 5 and providing the following 
information:
    Leader's Name: Dr. Geoffrey Evans.
    Password: ACCV.
    Agenda: The agenda items for the December meeting will include, 
but are not limited to: updates from the Division of Vaccine Injury 
Compensation (DVIC), Department of Justice, National Vaccine Program 
Office, Immunization Safety Office (Centers for Disease Control and 
Prevention), National Institute of Allergy and Infectious Diseases 
(National Institutes of Health), and Center for Biologics, 
Evaluation and Research (Food and Drug Administration). Agenda items 
are subject to change as priorities dictate.
    Public Comments: Persons interested in providing an oral 
presentation should submit a written request, along with a copy of 
their presentation to: Annie Herzog, DVIC, Healthcare Systems Bureau 
(HSB), Health Resources and Services Administration (HRSA), Room 
11C-26, 5600 Fishers Lane, Rockville, Maryland 20857 or e-mail: 
aherzog@hrsa.gov. Requests should contain the name, address, 
telephone number, and any business or professional affiliation of 
the person desiring to make an oral presentation. Groups having 
similar interests are requested to combine their comments and 
present them through a single representative. The allocation of time 
may be adjusted to accommodate the level of expressed interest. DVIC 
will notify each presenter by mail or telephone of their assigned 
presentation time. Persons who do not file an advance request for a 
presentation, but desire to make an oral statement, may announce it 
at the time of the comment period. These persons will be allocated 
time as it permits.
    For Further Information Contact: Anyone requiring information 
regarding the ACCV should contact Annie Herzog, DVIC, HSB, HRSA, 
Room 11C-26, 5600 Fishers Lane, Rockville, MD 20857; telephone (301) 
443-6593 or e-mail: aherzog@hrsa.gov.

    Dated: November 4, 2009.
Alexandra Huttinger,
Director, Division of Policy Review and Coordination.
[FR Doc. E9-27158 Filed 11-10-09; 8:45 am]
BILLING CODE 4165-15-P